Published in Neurosurgery on October 01, 1997
Sturge-Weber syndrome. Childs Nerv Syst (2006) 1.21
Brain Vascular Malformation Consortium: Overview, Progress and Future Directions. J Rare Disord (2013) 1.12
Clinical correlates of white matter blood flow perfusion changes in Sturge-Weber syndrome: a dynamic MR perfusion-weighted imaging study. AJNR Am J Neuroradiol (2011) 0.84
Ophthalmic Alterations in the Sturge-Weber Syndrome, Klippel-Trenaunay Syndrome, and the Phakomatosis Pigmentovascularis: An Independent Group of Conditions? Biomed Res Int (2015) 0.83
Current Therapeutic Options in Sturge-Weber Syndrome. Semin Pediatr Neurol (2015) 0.79
Increased L-[1-11 C] leucine uptake in the leptomeningeal angioma of sturge-weber syndrome: a PET study. J Neuroimaging (2011) 0.75
Clinical and morphological characteristics of head-facial haemangiomas. Head Face Med (2007) 0.75
Hemi-body port-wine stains and progressive paresis due to territorial perineuriomas. Skeletal Radiol (2013) 0.75
Cerebral autoregulation. Cerebrovasc Brain Metab Rev (1990) 5.13
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol (1990) 3.25
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol (1993) 3.07
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept (1984) 2.27
Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand (1983) 2.20
Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia (1997) 1.78
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol (1988) 1.77
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain (1994) 1.72
Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia (1996) 1.69
Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A (1986) 1.65
The concept of coupling blood flow to brain function: revision required? Ann Neurol (1987) 1.58
Pharmacological characterization of adrenergic alpha and beta receptors mediating the vasomotor responses of cerebral arteries in vitro. Circ Res (1974) 1.46
Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol (1984) 1.46
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45
The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5). J Auton Nerv Syst (1987) 1.44
Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ Res (1978) 1.42
Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res (1976) 1.42
Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther (1985) 1.34
Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett (1985) 1.29
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol (2000) 1.23
Capsaicin induces a depletion of calcitonin gene-related peptide (CGRP)-immunoreactive nerves in the cardiovascular system of the guinea pig and rat. J Auton Nerv Syst (1986) 1.23
Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept (1986) 1.22
Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol (1981) 1.22
Amine mechanisms in the cerebral circulation. Pharmacol Rev (1976) 1.21
Neurogenic mechanisms in the cerebrovascular bed. Autonomic nerves, amine receptors and their effects on cerebral blood flow. Acta Physiol Scand Suppl (1975) 1.19
The peptidergic innervation of the human superficial temporal artery: immunohistochemistry, ultrastructure, and vasomotility. Peptides (1995) 1.17
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience (2010) 1.15
Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand (1985) 1.15
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15
Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol (1993) 1.11
Neuronal messengers in the human cerebral circulation. Peptides (2001) 1.10
5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res (2001) 1.09
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol (1999) 1.09
VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Res (1980) 1.08
Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia (1992) 1.07
A pharmacologic comparison of histamine receptors in isolated extracranial and intracranial arteries in vitro. Neurology (1975) 1.07
Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology. Ann Neurol (1987) 1.07
Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig. Regul Pept (1985) 1.07
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett (1985) 1.07
Cutaneous vascular reactivity is reduced in aging and in heart failure: association with inflammation. Clin Sci (Lond) (2003) 1.07
On the pathogenesis of regional cerebral ischemia in intracranial hemorrhage: a causal influence of potassium? Pediatr Res (1986) 1.07
Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides (1990) 1.06
Ultrastructural evidence for the coexistence of calcitonin gene-related peptide and substance P in secretory vesicles of peripheral nerves in the guinea pig. J Neurocytol (1986) 1.05
A novel ETA-receptor antagonist, FR 139317, inhibits endothelin-induced contractions of guinea-pig pulmonary arteries, but not trachea. Br J Pharmacol (1993) 1.05
5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand (1993) 1.05
Physiological role of cerebrovascular sympathetic nerves in the autoregulation of cerebral blood flow. Brain Res (1976) 1.04
Effects of topical application of a calcium antagonist (nifedipine) on feline cortical pial microvasculature under normal conditions and in focal ischemia. J Cereb Blood Flow Metab (1983) 1.04
Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Br J Pharmacol (1999) 1.04
Characterization of adenosine receptors in isolated cerebral arteries of cat. Br J Pharmacol (1983) 1.02
Evidence for multiple endothelin receptors in the guinea-pig pulmonary artery and trachea. Br J Pharmacol (1992) 1.02
Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur J Neurol (2006) 1.02
Effect of stimulation of the sphenopalatine ganglion on cortical blood flow in the rat. J Cereb Blood Flow Metab (1988) 1.02
Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide. Am J Physiol (1980) 1.02
Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater. Cell Tissue Res (1983) 1.01
Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur J Pharmacol (1995) 1.00
Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Basic Res Cardiol (2006) 1.00
Immunohistochemical and ultrastructural localisation of peptide-containing nerves and myocardial cells in the human atrial appendage. Cell Tissue Res (1988) 0.99
Pharmacological characterization of GABA receptors mediating vasodilation of verebral arteries in vitro. Brain Res (1979) 0.99
Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries. J Cereb Blood Flow Metab (1981) 0.99
Comparison of the effects of potassium and pH on the calibre of cerebral veins and arteries. Pflugers Arch (1982) 0.99
Catecholamines and the relationship between cerebral blood flow and glucose use. Am J Physiol (1986) 0.99
Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst (1999) 0.99
Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol (1996) 0.99
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res (1999) 0.98
Influence of initial tension and changes in sensitivity during amine-induced contractions of pial arteries in vitro. Arch Int Pharmacodyn Ther (1974) 0.98
Neuropeptides in the cerebral circulation. Cerebrovasc Brain Metab Rev (1989) 0.97
Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides (1998) 0.97
Selective up-regulation of 5-HT(1B/1D) receptors during organ culture of cerebral arteries. Neuroreport (2001) 0.97
Heterogeneous vasomotor responses of anatomically distinct feline cerebral arteries. Br J Pharmacol (1988) 0.97
VIP nerve fibres around peripheral blood vessels. Acta Physiol Scand (1981) 0.96
Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand (1984) 0.96
Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci (1999) 0.96
Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate. J Pharmacol Exp Ther (2000) 0.95
Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regul Pept (1994) 0.95
Pharmacological characterization of postjunctional alpha-adrenoceptors in isolated feline cerebral and peripheral arteries. Acta Physiol Scand (1983) 0.95
Feline cerebral veins and arteries: comparison of autonomic innervation and vasomotor responses. J Physiol (1982) 0.95
P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation. Br J Pharmacol (1998) 0.95
Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacology (Berl) (1987) 0.94
Sympathetic nervous control of cerebrospinal fluid production from the choroid plexus. Science (1978) 0.94
Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. J Auton Nerv Syst (1989) 0.94
Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ. J Cereb Blood Flow Metab (1991) 0.94
Action of dopamine agonists on brain vessels in vitro and after in vivo microapplication. Acta Neurol Scand Suppl (1977) 0.94
Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol (1986) 0.94
Indoleaminergic mechanisms in brain vessels; localization, concentration, uptake and in vitro responses of 5-hydroxytryptamine. Acta Physiol Scand (1984) 0.93
Central serotonergic nerves project to the pial vessels of the brain. Nature (1983) 0.93
Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane. Hum Mutat (1999) 0.93
Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. Acta Physiol Scand (1998) 0.93
Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides (1991) 0.93
Peptidergic (VIP) innervation of the esophagus. Gastroenterology (1978) 0.93
Peptides in the mammalian cardiovascular system. Experientia (1987) 0.92
Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. J Pharmacol Exp Ther (2010) 0.92
Calcium antagonists: effects on cerebral blood flow and blood-brain barrier permeability in the rat. Br J Pharmacol (1983) 0.92
An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia (2002) 0.92
Evidence that ET-1, but not ET-3 and S6b, ET(A)-receptor mediated contractions in isolated rat mesenteric arteries are modulated by co-activation of ET(B) receptors. Br J Pharmacol (2001) 0.91
Central projections of sensory innervation of the rat superior sagittal sinus. Neuroscience (2004) 0.91
Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels. Acta Physiol Scand (1978) 0.91